Premature Ventricular Complex Ablation in Structural Heart Disease.

Area of Science:

• Cardiology
• Electrophysiology
• Cardiac Surgery

Background:

• Frequent premature ventricular complexes (PVCs) in patients with structural heart disease, especially post-myocardial infarction, are linked to increased mortality.
• Antiarrhythmic drug therapy for PVCs in this population can paradoxically increase mortality.
• High PVC burdens can induce or exacerbate cardiomyopathy and trigger life-threatening ventricular arrhythmias.

Purpose of the Study:

• To evaluate the impact of PVCs on mortality and cardiac function in patients with structural heart disease.
• To assess the efficacy and safety of catheter ablation as a treatment for frequent PVCs in this high-risk group.
• To explore the role of PVC ablation in preventing malignant ventricular arrhythmias.

Main Methods:

• Retrospective analysis of patients with structural heart disease and frequent PVCs.
• Comparison of outcomes between patients treated with antiarrhythmic drugs versus catheter ablation.
• Mapping and ablation of PVCs guided by electrophysiological studies.

Main Results:

• Catheter ablation successfully eliminated PVCs in a significant majority of patients.
• Elimination of PVCs led to improvement or normalization of cardiac function and reduced cardiomyopathy.
• Patients undergoing ablation experienced a lower incidence of malignant ventricular arrhythmias compared to those on antiarrhythmic drugs.

Conclusions:

• Catheter ablation is a safe and effective strategy for managing frequent PVCs in patients with structural heart disease.
• PVC elimination through ablation improves cardiac function and reduces mortality risk.
• Ablation of PVCs is crucial for preventing further cardiac events, particularly in post-myocardial infarction patients.